Aging-Related Disease

Roughly 55 million people live with dementia worldwide; the figure is projected to reach 139 million by 2050 as populations age. Alzheimer's accounts for 60–70% of dementia cases. Parkinson's disease affects roughly 10 million people globally and is among the fastest-growing neurological conditions. Combined, neurodegenerative diseases will be the dominant burden of the demographic transition in advanced economies.

55M
People living with dementia worldwide
139M
Projected dementia cases 2050
10M
Living with Parkinson's disease
$1.3T
Annual global cost of dementia

Key insights

🧠

Dementia is the leading aging-related condition

Alzheimer's disease causes 60–70% of dementia cases. Other major causes: vascular dementia (cerebrovascular damage), Lewy body dementia, frontotemporal dementia. Prevalence rises sharply with age — 5% at 65, 10% at 75, 30% at 85, 50% at 95. As life expectancy rises, exposure to high-prevalence age bands increases, multiplying total cases regardless of underlying biology.

📉

First disease-modifying treatments are now FDA-approved

Lecanemab (full approval 2023) and donanemab (2024) are the first FDA-approved Alzheimer's drugs shown to slow disease progression rather than just treating symptoms; aducanumab (2021) came first on an accelerated basis, but its maker withdrew it in 2024. Effects are modest — roughly a quarter to a third slower cognitive decline over 18 months in trials — and access remains limited by cost, infusion requirements, and ARIA (amyloid-related imaging abnormalities) side-effects. The pipeline behind these is the largest in decades.

🇯🇵

Asian aging will drive future case loads

Japan currently has the highest dementia prevalence (~12% of those over 65) due to its aging population. China is projected to have the largest absolute case load by 2050 (~28 million cases). Asia already has more cases than Europe and the Americas combined. Healthcare and long-term care infrastructure in many Asian countries is significantly less prepared for this than in Western Europe or North America.

Projected dementia cases 2024–2050

Millions of people, by region

Show data table
Projected dementia cases 2024–2050
Millions of cases
Asia 202426
Asia 205071
Europe 202411
Europe 205018
Americas 202411
Americas 205028
Africa 20243
Africa 205011

Key Finding: Total cases rise about 2.5 times by 2050; Asia shows the largest absolute growth and Africa the fastest proportional growth.

Dementia prevalence — selected countries (2024)

% of population 60+ living with dementia

Show data table
Dementia prevalence — selected countries (2024)
% 60+ with dementia
Japan12
Italy8.5
Germany7.5
UK7.5
Sweden7
Spain7.2
France6.8
USA5.5
World5
China4.5
Brazil4.3
India3.8
Nigeria2

Key Finding: Japan and Italy lead due to old populations; African countries have lower prevalence partly due to lower life expectancy.

Methodology & caveats

Diagnosis underestimates true prevalence

Many people with dementia are undiagnosed — estimates range from 40% (high-income countries) to 80% (low-income countries) of cases. Diagnosis requires cognitive testing, brain imaging, and clinical assessment that are not always accessible. Prevalence statistics partly reflect diagnostic capacity; comparisons across countries should account for this.

Prevention is starting to be possible

Lancet Commission 2024 reviewed evidence that 45% of dementia cases could be prevented or delayed by addressing 14 modifiable risk factors — less education, hearing loss, depression, head injury, hypertension, obesity, smoking, physical inactivity, diabetes, excessive alcohol, social isolation, air pollution, untreated vision loss, high cholesterol. The window for prevention is mostly midlife (40-65).

Cost calculation

Direct costs (medical care, long-term care) and indirect costs (unpaid family caregiving, lost productivity) for dementia globally are estimated at $1.3T per year. About half of total costs are informal caregiving, on WHO estimates — primarily unpaid family labor, mostly female. Aging societies face simultaneous shrinking of working-age population and rising demand for caregiver labor — the policy crunch is structural.

Why dementia counts differ

The 55 million figure comes from WHO and Alzheimer's Disease International, while the 139 million projection applies today's age-specific rates to UN population forecasts. The Global Burden of Disease study, which uses different case definitions, produces its own higher projection of about 153 million by 2050. Neither is a census: most low-income estimates are extrapolated from a few community surveys.

What would change the projection

Projections assume age-specific risk stays constant, yet cohort studies in the UK, USA and northern Europe found that a person of a given age today is less likely to develop dementia than one a generation ago, probably because of more education and better vascular health. If that trend spreads, the 2050 total will be too high. Rising diabetes and obesity push the other way. Blood-based biomarker tests could also raise recorded prevalence by diagnosing people earlier, without any change in true risk.

Cite this page

GlobeChart. “Aging-Related Disease.” Last updated 2026-10-31. https://globechart.com/health/aging-disease/

Please also credit the original publisher named under each chart: Alzheimer's Disease International World Alzheimer Report 2024; WHO Global Dementia Observatory, ADI 2024. Spotted an error? Tell us.